IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 202 filers reported holding IMPAX LABORATORIES INC in Q4 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,518,000 | +1235.3% | 386,546 | +1042.2% | 0.01% | +900.0% |
| Q4 2017 | $563,000 | -90.1% | 33,842 | -87.9% | 0.00% | -88.9% |
| Q3 2017 | $5,666,000 | -19.3% | 279,115 | -36.0% | 0.01% | -30.8% |
| Q2 2017 | $7,019,000 | -76.9% | 435,969 | -81.9% | 0.01% | -76.8% |
| Q1 2017 | $30,446,000 | +1048.9% | 2,406,770 | +1103.3% | 0.06% | +833.3% |
| Q4 2016 | $2,650,000 | +123.6% | 200,015 | +300.0% | 0.01% | +200.0% |
| Q3 2016 | $1,185,000 | -88.0% | 50,000 | -85.5% | 0.00% | -91.3% |
| Q2 2016 | $9,909,000 | -50.3% | 343,809 | -44.8% | 0.02% | -54.0% |
| Q1 2016 | $19,944,000 | -33.2% | 622,858 | -10.8% | 0.05% | -20.6% |
| Q4 2015 | $29,845,000 | +117.5% | 697,956 | +79.1% | 0.06% | +133.3% |
| Q3 2015 | $13,720,000 | -46.8% | 389,655 | -30.6% | 0.03% | -44.9% |
| Q2 2015 | $25,797,000 | +54.0% | 561,783 | +57.2% | 0.05% | +58.1% |
| Q1 2015 | $16,748,000 | +30.7% | 357,326 | -11.7% | 0.03% | +14.8% |
| Q4 2014 | $12,818,000 | +289.2% | 404,596 | +191.3% | 0.03% | +237.5% |
| Q3 2014 | $3,293,000 | -67.5% | 138,893 | -58.9% | 0.01% | -71.4% |
| Q2 2014 | $10,133,000 | -67.6% | 337,890 | -71.5% | 0.03% | -69.2% |
| Q1 2014 | $31,300,000 | +74.5% | 1,184,725 | +66.0% | 0.09% | +59.6% |
| Q4 2013 | $17,939,000 | -5.8% | 713,554 | -23.3% | 0.06% | -6.6% |
| Q3 2013 | $19,045,000 | -16.3% | 930,396 | -18.5% | 0.06% | -12.9% |
| Q2 2013 | $22,766,000 | – | 1,141,826 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |